TriRx Pharmaceutical Services (TriRx), our exclusive sponsor of semi-solids, is a contract development and manufacturing organization that serves the global biopharmaceutical market. Headquartered approximately 50 miles outside of New York City in Norwalk, Connecticut, TriRx operates facilities providing state-of-the-art laboratory, manufacturing, packaging, and warehousing capabilities.
Founded and led by Tim Tyson and a team of experienced industry leaders, TriRx has technical expertise and a multifaceted understanding of customer needs. This depth of understanding and commitment provides TriRx with the knowledge to deliver exceptional service while consistently meeting or exceeding customer expectations.
How is TriRx contributing to the future of healthcare?
The recent COVID-19 pandemic has highlighted the importance of pharmaceutical innovation in addressing market needs. As an industry leader in liquid and semi-solid manufacturing, TriRx contributes to the future of healthcare by delivering on their promises on time and in full, serving as a committed CDMO partner as the industry develops innovative therapeutics and vaccines. TriRx is also focused on exploring new technologies, such as robotics, nanoparticle technology, controlled release technology, laser printing, process analytical technologies (PATs), and 3D printing, which can be integrated to bolster their offerings.
With the industry landscape constantly evolving, TriRx has already incorporated robotics, serialization, and cloud-based enterprise resource planning (ERP) to improve operations. The company is continually seeking new opportunities for innovation while expanding its capacity and capabilities and improving efficiencies to support the biopharmaceutical industry and deliver life-saving medications to patients around the world.